Peripheral Arterial Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 19 years or older
- People who are able to give informed consent before any trial activities begin
- People who have been diagnosed with peripheral artery disease (PAD) causing leg pain or cramping when walking, at a stage where they can walk more than 200 metres (about 2 blocks) before needing to stop, and have had these stable symptoms for at least 90 days before the screening appointment
- People whose PAD has been confirmed by a specific test result — either a low ankle-to-arm blood pressure comparison score (0.90 or below), or a significant narrowing in a leg artery shown by imaging tests, or a history of a procedure to restore blood flow in the legs
Who may not be able to join:
- People who have used any medication that affects the immune system within the 90 days before screening
- People whose ability to walk is limited by a condition other than PAD
- People who have a leg orthopaedic surgery or other major surgery that affects walking ability planned at the time of screening
- People who had a procedure to restore blood flow in leg arteries within the 180 days before screening
- People who have an arterial blood flow procedure planned at the time of screening
- People who have had a heart attack, stroke, hospitalisation for severe chest pain, or a mini-stroke within the 180 days before screening
- People with heart failure that causes significant symptoms even with minimal activity or at rest (confirm with trial site)
- People who have signs of severe reduced blood flow to the legs, such as gangrene, pain at rest, or wounds that are not healing
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Christopher Fordyce, MD MHS MSc FRCPC, Vancouver General Hospital
Phone: 604 875-5324
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
6-Minute Walk Test (6MWT)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.